agilon health, inc. earnings per share and revenue
On 04 de nov. de 2025, AGL reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of -0.15 USD, resulting in a -68.86% surprise. Revenue reached 1.44 bilhão, compared to an expected 1.44 bilhão, with a -0.16% difference. The market reacted with a +4.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.27 USD, with revenue projected to reach 1.48 bilhão USD, implying an aumentar of 0.00% EPS, and aumentar of 2.81% in Revenue from the last quarter.
FAQ
What were agilon health, inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, agilon health, inc. reported EPS of -$0.27, missing estimates by -68.86%, and revenue of $1.44B, -0.16% below expectations.
How did the market react to agilon health, inc.'s Q3 2025 earnings?
The stock price moved up 4.05%, changed from $0.72 before the earnings release to $0.75 the day after.
When is agilon health, inc. expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for agilon health, inc.'s next earnings report?
Based on 17
analistas, agilon health, inc. is expected to report EPS of -$0.27 and revenue of $1.48B for Q4 2025.